China · Delayed Price · Currency is CNY R&G PharmaStudies Statistics
Total Valuation
SHE:301333 has a market cap or net worth of CNY 5.91 billion. The enterprise value is 4.22 billion.
| Market Cap | 5.91B |
| Enterprise Value | 4.22B |
Important Dates
The last earnings date was Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | Jul 8, 2025 |
Share Statistics
SHE:301333 has 95.14 million shares outstanding. The number of shares has increased by 0.36% in one year.
| Current Share Class | 95.14M |
| Shares Outstanding | 95.14M |
| Shares Change (YoY) | +0.36% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 12.43% |
| Owned by Institutions (%) | 20.97% |
| Float | 30.59M |
Valuation Ratios
The trailing PE ratio is 43.45 and the forward PE ratio is 35.91.
| PE Ratio | 43.45 |
| Forward PE | 35.91 |
| PS Ratio | 6.95 |
| PB Ratio | 2.99 |
| P/TBV Ratio | 3.17 |
| P/FCF Ratio | 62.27 |
| P/OCF Ratio | 51.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.45, with an EV/FCF ratio of 44.41.
| EV / Earnings | 30.79 |
| EV / Sales | 4.95 |
| EV / EBITDA | 26.45 |
| EV / EBIT | 31.22 |
| EV / FCF | 44.41 |
Financial Position
The company has a current ratio of 5.60, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.60 |
| Quick Ratio | 5.42 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.28 |
| Debt / FCF | 0.47 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.26% and return on invested capital (ROIC) is 49.32%.
| Return on Equity (ROE) | 7.26% |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | 49.32% |
| Return on Capital Employed (ROCE) | 6.70% |
| Weighted Average Cost of Capital (WACC) | 8.10% |
| Revenue Per Employee | 385,420 |
| Profits Per Employee | 62,002 |
| Employee Count | 2,208 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 8.94 |
Taxes
In the past 12 months, SHE:301333 has paid 16.85 million in taxes.
| Income Tax | 16.85M |
| Effective Tax Rate | 10.86% |
Stock Price Statistics
The stock price has increased by +20.78% in the last 52 weeks. The beta is 0.71, so SHE:301333's price volatility has been lower than the market average.
| Beta (5Y) | 0.71 |
| 52-Week Price Change | +20.78% |
| 50-Day Moving Average | 69.84 |
| 200-Day Moving Average | 58.81 |
| Relative Strength Index (RSI) | 45.05 |
| Average Volume (20 Days) | 1,637,011 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301333 had revenue of CNY 851.01 million and earned 136.90 million in profits. Earnings per share was 1.43.
| Revenue | 851.01M |
| Gross Profit | 295.64M |
| Operating Income | 135.02M |
| Pretax Income | 155.15M |
| Net Income | 136.90M |
| EBITDA | 157.10M |
| EBIT | 135.02M |
| Earnings Per Share (EPS) | 1.43 |
Balance Sheet
The company has 1.75 billion in cash and 44.53 million in debt, with a net cash position of 1.70 billion or 17.90 per share.
| Cash & Cash Equivalents | 1.75B |
| Total Debt | 44.53M |
| Net Cash | 1.70B |
| Net Cash Per Share | 17.90 |
| Equity (Book Value) | 1.98B |
| Book Value Per Share | 20.45 |
| Working Capital | 1.77B |
Cash Flow
In the last 12 months, operating cash flow was 114.20 million and capital expenditures -19.28 million, giving a free cash flow of 94.93 million.
| Operating Cash Flow | 114.20M |
| Capital Expenditures | -19.28M |
| Depreciation & Amortization | 22.08M |
| Net Borrowing | -55.14M |
| Free Cash Flow | 94.93M |
| FCF Per Share | 1.00 |
Margins
Gross margin is 34.74%, with operating and profit margins of 15.87% and 16.09%.
| Gross Margin | 34.74% |
| Operating Margin | 15.87% |
| Pretax Margin | 18.23% |
| Profit Margin | 16.09% |
| EBITDA Margin | 18.46% |
| EBIT Margin | 15.87% |
| FCF Margin | 11.15% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 0.26%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 0.26% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.61% |
| Buyback Yield | -0.36% |
| Shareholder Yield | -0.10% |
| Earnings Yield | 2.32% |
| FCF Yield | 1.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 29, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 29, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |